Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer [Phase 2]
Phase II clinical trial evaluating Serplulimab in combination with first-line targeted therapy, chemotherapy, and radiation for advanced col…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Effect of Arm Cycling Exercise on Pulmonary Functions After Colectomy In Elderly [NA]
An update on a clinical trial assessing whether arm cycling exercise improves pulmonary function after colectomy in elderly patients; the st…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients [Phase 2]
Phase 2 trial evaluating nivolumab in combination with FOLFOXIRI and bevacizumab as first-line therapy for advanced colorectal cancer with R…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer
This retrospective study examines the real-world use of immunotherapy in patients with MSI-H metastatic colorectal cancer to evaluate outcom…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: The Effect of Oral Carbohydrate Administration on Postoperative Well-being [NA]
A completed clinical trial evaluating whether oral carbohydrate administration improves postoperative well-being in colorectal cancer patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Clinical Trial Evaluating External Evaluation and Training on the Incomplete Resection (POLIPEVA Study) [NA]
The POLIPEVA study, a clinical trial evaluating external evaluation and training to address incomplete resections in colorectal lesions, has…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery [Phase 1]
Phase 1 trial in colorectal cancer evaluating ezabenlimab or pembrolizumab in combination with BI 765063; the study was terminated and resul…
-
CLINICAL_TRIALS other · 2025-03-13Clinical Trial Update: Specific Training After Stoma Surgery [NA]
A Göteborg University-sponsored clinical trial is evaluating specific training after stoma surgery for colon cancer, and it is currently rec…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes [NA]
A clinical trial update notes an active-not-recruiting study evaluating the impact of a colorectal cancer and nutrition education program am…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal Cancer [Phase 2]
A Phase 2 clinical trial evaluating different cycles of preoperative neoadjuvant sintilimab in patients with mismatch-repair deficient/micro…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis [NA]
This ClinicalTrials.gov entry reports the validation of miRFec, a microRNA-based fecal test for colorectal cancer screening, surveillance, a…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.
Multi-center study protocol assessing how sarcopenia affects prognosis in early-onset colorectal cancer; enrollment is by invitation.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Versius or Laparoscopic Colorectal Cancer and Non-cancer Operation Outcomes
The clinical trial update reports completed outcomes for Versius robotic-assisted colorectal procedures compared with laparoscopic technique…
-
CLINICAL_TRIALS withdrawal · 2025-03-12Clinical Trial Update: UNTIRE: Cancer-related Fatigue With Digital Treatment [NA]
A clinical trial (UNTIRE) evaluating a digital treatment for cancer-related fatigue in colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR) [EARLY_Phase 1]
Phase I/II study of Fragmented Autoantigen Stimulated T-cell-immunotherapy (FAST-CR) combined with radiotherapy. The trial targets breast ca…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: A Study of JMT203 in Patients With Cancer Cachexia [Phase 1]
Phase 1 trial evaluating JMT203 in cancer cachexia, including colorectal cancer and non-small cell lung cancer (also mentioning pancreatic c…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Comparisons of Endo-Wing-assisted Colonoscopy Versus Standard Colonoscopy in Improving Adenoma Detection Rate in Symptomatic Patients Suspected of Colorectal Cancer [NA]
A completed clinical trial comparing Endo-Wing-assisted colonoscopy with standard colonoscopy to assess adenoma detection rate in symptomati…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BEY1107 in combination with capecitabine for metastatic colorectal cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of TBio-4101 (TIL) with pembrolizumab in advanced solid tumors has been terminated; the trial includes multiple indications su…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) [Phase 2]
Phase 2 clinical trial update on pixatimod (PG545) plus nivolumab in PD-1 relapsed/refractory metastatic melanoma and non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer [Phase 2]
Phase 2 clinical trial evaluating Taxol (paclitaxel) given intravenously and intraperitoneally with Tasigna (nilotinib) taken orally for per…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam
This clinical trial evaluates the predictive value of PREMM5, MMRpredict, and universal tumor screening for Lynch syndrome in Vietnam, with …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy [NA]
This clinical trial update reports the completion of a study evaluating adenoma detection rate using artificial intelligence-assisted colono…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: MGD019 DART® Protein in Unresectable/Metastatic Cancer [Phase 1]
MGD019, a DART protein from MacroGenics, is being studied in a Phase 1 trial for unresectable/metastatic cancers, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
A completed multicancer registry study (PREFER) assessing the prevalence of actionable biomarkers and driver mutations across advanced cance…